United KingdomOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3,651 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92,849 | 100,395 |
| Total Cites | 16,518 | 18,574 |
| H-index | 68 | 74 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 2,134 | 2,237 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 3,680 | 3,927 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,968 | 14,012 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.33 |
| Self-Citation Percentage |
11.07%
|
|
United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3,455 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85,204 | 92,601 |
| Total Cites | 17,259 | 19,412 |
| H-index | 69 | 73 |
| Hm-index | 20 | 22 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 2,038 | 2,141 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 3,489 | 3,733 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13,666 | 14,735 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.32 |
| Self-Citation Percentage |
11.09%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3,271 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 80,042 | 87,184 |
| Total Cites | 16,161 | 18,185 |
| H-index | 67 | 71 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 1,936 | 2,039 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 3,287 | 3,520 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,864 | 13,875 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.31 |
| Self-Citation Percentage |
11.13%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3,252 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79,689 | 86,277 |
| Total Cites | 15,445 | 17,402 |
| H-index | 65 | 69 |
| Hm-index | 19 | 21 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 1,877 | 1,979 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 3,071 | 3,299 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,304 | 13,286 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.31 |
| Self-Citation Percentage |
11.25%
|
|
Trending Researchers
Top 2% Scientists by Country
United Kingdom18,125 scientists, 3rd in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.